Skip to search formSkip to main contentSkip to account menu

MK-7009

Known as: MK 7009, MK7009 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Background Some drugs that are actively taken up into the liver exhibit greater than dose proportional increases in plasma… 
2014
2014
BackgroundVaniprevir (MK-7009) is a hepatitis C virus (HCV) non-structural 3/4a protease inhibitor which significantly increases… 
2011
2011
Development of a practical synthesis of MK-7009, a 20-membered [corrected] macrocycle, is described. A variety of ring-closing… 
Highly Cited
2010
Highly Cited
2010
ABSTRACT In order to assess the natural variation in susceptibility to hepatitis C virus (HCV) NS3 protease inhibitors (PIs… 
Highly Cited
2010
Highly Cited
2010
ABSTRACT Efforts to develop novel, interferon-sparing therapies for treatment of chronic hepatitis C (HCV) infection are…